Abstract:Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling, thereby avoiding many of the ethical issues arising from the use of embryo-derived cells. However, despite clear similarities between the two cell types, it is likely they are not identical. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors. We find that while hESCs and hiPSCs express a near identical set of proteins, they show consistent quantitative differences in the expression levels of a wide subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs. The proteomic data show hiPSCs have significantly increased abundance of vital cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins, which correlated with phenotypic differences between hiPSCs and hESCs. Thus, higher levels of glutamine transporters correlated with increased glutamine uptake, while higher levels of proteins involved in lipid synthesis correlated with increased lipid droplet formation. Some of the biggest metabolic changes were seen in proteins involved in mitochondrial metabolism, with corresponding enhanced mitochondrial potential, shown experimentally using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including ECM components and growth factors, some with known tumorigenic properties, as well as proteins involved in the inhibition of the immune system. Our data indicate that reprogramming of human fibroblasts to iPSCs effectively restores protein expression in cell nuclei to a state comparable to hESCs, but does not similarly restore the profile of cytoplasmic and mitochondrial proteins, with consequences for cell phenotypes affecting growth and metabolism. The data improve understanding of the molecular differences between induced and embryonic stem cells, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

Comparative functional genomics identifies unique molecular features of EPSCs

Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures

Association of Telomere Length with Authentic Pluripotency of ES/iPS Cells.

Computer and Statistical Analysis of Transcription Factor Binding and Chromatin Modifications by ChIP-seq Data in Embryonic Stem Cell

Network plasticity of pluripotency transcription factors in embryonic stem cells

Translational and post-translational control of human naïve versus primed pluripotency

Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells.

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Ipscs Are Transcriptionally and Post-Transcriptionally Indistinguishable from Fescs.

Defining Differentially Methylated Regions Specific For The Acquisition Of Pluripotency And Maintenance In Human Pluripotent Stem Cells Via Microarray

Proteomic and functional comparison between human induced and embryonic stem cells

Epiblast-like stem cells established by Wnt/β-catenin signaling manifest distinct features of formative pluripotency and germline competence

Tackling the Epigenome in the Pluripotent Stem Cells

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs

Single-cell Analyses of X Chromosome Inactivation Dynamics and Pluripotency During Differentiation.

Transcriptomic and Epigenomic Resemblance of Terminally Differentiated Cells Derived from Isogenic Human Ipscs and Nuclear Transfer Derived Escs

An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells.

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs

YY1 safeguard multidimensional epigenetic landscape associated with extended pluripotency

Comparative analysis of naive, primed and ground state pluripotency in mouse embryonic stem cells originating from the same genetic background